Neural Regeneration Protocol: Selective Degradation via MRI-Activated Nanoparticles

Abstract This article presents a technical protocol, released under a public domain license, aimed at reversing central nervous system (CNS) lesions caused by glial scar formation. The proposed system employs a precision delivery vehicle—nanoparticles functionalized with amino acids (LAT1 ligands)—to cross the blood–brain barrier (BBB) non‑invasively. Controlled activation via an external electromagnetic field (magnetic resonance imaging) enables the release of proteolytic enzymes into the scar, followed by a calibrated cocktail of neurotrophic growth factors that guide targeted cell differentiation in the injured region. The protocol integrates replicated biological signaling (chemokines, cytokines, growth factors) with systems engineering principles, replacing invasive surgical interventions. Imaging checkpoints, dosage control, and systemic anti‑inflammatory support ensure safety and reproducibility. The objective is to accelerate global collaboration in regenerative neuroscience by establishing an open, non‑proprietary framework for therapeutic development.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-07-18
DOI
https://doi.org/10.5281/zenodo.21433719
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neural Regeneration Protocol: Selective Degradation via MRI-Activated Nanoparticles

Adalberto Souza
Zenodo (CERN European Organization for Nuclear Research)
Glioma Diagnosis and Treatment
article

Neural Regeneration Protocol: Selective Degradation via MRI-Activated Nanoparticles

Adalberto Souza
article en

Abstract

Abstract This article presents a technical protocol, released under a public domain license, aimed at reversing central nervous system (CNS) lesions caused by glial scar formation. The proposed system employs a precision delivery vehicle—nanoparticles functionalized with amino acids (LAT1 ligands)—to cross the blood–brain barrier (BBB) non‑invasively. Controlled activation via an external electromagnetic field (magnetic resonance imaging) enables the release of proteolytic enzymes into the scar, followed by a calibrated cocktail of neurotrophic growth factors that guide targeted cell differentiation in the injured region. The protocol integrates replicated biological signaling (chemokines, cytokines, growth factors) with systems engineering principles, replacing invasive surgical interventions. Imaging checkpoints, dosage control, and systemic anti‑inflammatory support ensure safety and reproducibility. The objective is to accelerate global collaboration in regenerative neuroscience by establishing an open, non‑proprietary framework for therapeutic development.

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals
Openalex Percentile: Top 8%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neural Regeneration Protocol: Selective Degradation via MRI-Activated Nanoparticles — Adalberto Souza · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS